Working… Menu

Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00972712
Recruitment Status : Completed
First Posted : September 7, 2009
Last Update Posted : March 10, 2015
Millennium Pharmaceuticals, Inc.
Ortho Biotech, Inc.
Information provided by (Responsible Party):
Sagar Lonial, Emory University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2009
Actual Study Completion Date : March 2015